The use of faecal microbiota transplant as treatment for recurrent or refractoryClostridium difficileinfection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Top Cited Papers
Open Access
- 28 August 2018
- Vol. 67 (11), 1920-1941
- https://doi.org/10.1136/gutjnl-2018-316818
Abstract
Interest in the therapeutic potential of faecal microbiota transplant (FMT) has been increasing globally in recent years, particularly as a result of randomised studies in which it has been used as an intervention. The main focus of these studies has been the treatment of recurrent or refractory Clostridium difficile infection (CDI), but there is also an emerging evidence base regarding potential applications in non-CDI settings. The key clinical stakeholders for the provision and governance of FMT services in the UK have tended to be in two major specialty areas: gastroenterology and microbiology/infectious diseases. While the National Institute for Health and Care Excellence (NICE) guidance (2014) for use of FMT for recurrent or refractory CDI has become accepted in the UK, clear evidence-based UK guidelines for FMT have been lacking. This resulted in discussions between the British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS), and a joint BSG/HIS FMT working group was established. This guideline document is the culmination of that joint dialogue.Keywords
Funding Information
- National Institute for Health Research
- Medical Research Council
This publication has 129 references indexed in Scilit:
- Treatment of relapsing Clostridium difficile infection using fecal microbiota transplantationClinical and Experimental Gastroenterology, 2013
- Impact of Colonoscopy Bowel Preparation on Intestinal MicrobiotaPLOS ONE, 2013
- Proton pump inhibitor therapy predisposes to community‐acquired Streptococcus pneumoniae pneumoniaAlimentary Pharmacology & Therapeutics, 2012
- Burden of Clostridium difficile on the Healthcare SystemClinical Infectious Diseases, 2012
- Standard Colonic Lavage Alters the Natural State of Mucosal-Associated Microbiota in the Human ColonPLOS ONE, 2012
- Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection in 26 PatientsJournal of Clinical Gastroenterology, 2012
- Treating Clostridium difficile Infection With Fecal Microbiota TransplantationClinical Gastroenterology and Hepatology, 2011
- Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case seriesQJM: An International Journal of Medicine, 2009
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Effect of bowel preparation and colonoscopy on post-procedure intestinal microbiota compositionGut, 2006